Nancy Wysenski
Affiliations
- Director at Cytokinetics Inc (CYTK), 2025-05-14
- Director at Alkermes Plc. (ALKS), 2023-07-11
- Director at Provention Bio Inc. (PRVB), 2023-04-27
- Director at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
- Director at Tetraphase Pharmaceuticals Inc (TTPH), 2019-06-11
- Director at Inovio Pharmaceuticals Inc. (INO), 2016-05-16
- Evp, Chief Commercial Officer at Vertex Pharmaceuticals Inc / Ma (VRTX), 2012-06-01
- Officer at Endo Pharmaceuticals Holdings Inc (ENDP), 2009-03-02
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ALKS | $19.65 | 6,940 | $136,371.00 | 11,242 | 2020-02-24 | Filing |
| ALKS | $33.06 | 445 | $14,711.70 | 4,302 | 2019-03-14 | Filing |
| ALKS | $33.09 | 3,857 | $127,628.13 | 3,857 | 2019-02-21 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ALKS | $31.24 | 41,250 | $1,288,786.13 | 15,829 | 2023-05-09 | Filing |
| VRTX | $65.00 | 372 | $24,180.00 | 32,232 | 2012-05-14 | Filing |
| VRTX | $64.27 | 179,628 | $11,544,691.56 | 32,604 | 2012-05-14 | Filing |
| VRTX | $65.00 | 372 | $24,180.00 | 32,232 | 2012-05-14 | Filing |
| VRTX | $64.27 | 179,628 | $11,544,691.56 | 32,604 | 2012-05-14 | Filing |